Trial NCT03531281

View at ClinicalTrials.gov 
Org. Study IDs: 17399
Secondary IDs: 17399 NCI-2018-00053

Last trial update was posted on 2018-12-07

MeSH Interventions

Cyclophosphamide Etoposide Etoposide phosphate Mitogens Podophyllotoxin Sirolimus Tacrolimus

MeSH Conditions

Hematologic Neoplasms

Other Conditions

Hematopoietic Cell Transplantation Recipient Hematopoietic and Lymphoid Cell Neoplasm

Stopping Reasons

Administratively withdrawn

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID